European Union Drugs Agency (EUDA)

Website
https://www.euda.europa.eu/

The European Union Drugs Agency (EUDA) is the leading authority on illicit drugs in Europe. Based in Lisbon, Portugal, the EUDA provides independent scientific evidence and analysis on all aspects of this constantly changing threat to individual lives and wider society. The EUDA contributes to EU and national policies to protect Europe's citizens from drug-related harms. It is an agency of the European Union.

Mission

Our new mission focuses on contributing to European Union (EU) preparedness on drugs through four main actions: anticipate, alert, respond, and learn.

Related Knowledge Share items

European Drugs Summer School 2021

 - 
Lisbon

The two week Summer School prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs. Teaching staff include scientific experts from the European Monitoring Centre for Drugs and Drug

European Drugs Winter School 2021

 - 
Europe

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are offering two upcoming events in 2021: the European Drugs Winter School (EDWS) and the European Drugs Summer School (EDSS).

The EDWS will take place as a virtual event from 1–12 March 2021 and will explore the theme of 'Responses to, and preparedness for, health-related threats (COVID-19 lessons learned)'. 

EMCDDA Technical Report on New Psychoactive Substance

Book
The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid...

EMCDDA webinar: COVID-19 induced recession and drug-related problems

 - 
Online

The EMCDDA is offering a series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience. The webinars will give a voice to key professionals working in the drugs field and will allow for a panel discussion on emerging challenges.